Drug supplement interactions stories

GLP-1 Drug Semaglutide Reduces Heavy Drinking Days by 50% in Alcohol Use Disorder Trial

A clinical trial of 108 adults with obesity and alcohol use disorder found that once-weekly semaglutide injections reduced heavy drinking days in the past 30 days by an average of roughly 12 days, representing a 50% reduction compared to placebo.